Skip to main content

Published locations for Icosapent ethyl’s CV mortality benefit magnified in patients with prior MI

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Icosapent ethyl’s CV mortality benefit magnified in patients with prior MI

User login

  • Reset your password
  • /content/icosapent-ethyls-cv-mortality-benefit-magnified-patients-prior-mi
  • /familypracticenews/article/254020/lipid-disorders/icosapent-ethyls-cv-mortality-benefit-magnified
  • /internalmedicinenews/article/254020/lipid-disorders/icosapent-ethyls-cv-mortality-benefit-magnified
  • /clinicalendocrinologynews/article/254020/lipid-disorders/icosapent-ethyls-cv-mortality-benefit
  • /ecardiologynews/article/254020/lipid-disorders/icosapent-ethyls-cv-mortality-benefit-magnified
  • /cardiology/article/254020/lipid-disorders/icosapent-ethyls-cv-mortality-benefit-magnified-patients
  • /endocrinology/article/254020/lipid-disorders/icosapent-ethyls-cv-mortality-benefit-magnified
  • /internalmedicine/article/254020/lipid-disorders/icosapent-ethyls-cv-mortality-benefit-magnified
  • /familymedicine/article/254020/lipid-disorders/icosapent-ethyls-cv-mortality-benefit-magnified
  • /chestphysician/article/254020/lipid-disorders/icosapent-ethyls-cv-mortality-benefit-magnified